Kathrin LaFaver, MD Kathrin LaFaver, MD, a neurologist and lifestyle medicine specialist from Saratoga Springs, New York, interviewed Dean Ornish, MD, the founder and president of the nonprofit Preventive Medicine Research Institute in Sausalito, California, and a clinical professor of medicine at the University of California in San Francisco and San Diego, about his recent study …
Stroke is a significant global health concern, contributing to high rates of morbidity, mortality, and disability. Although there is limited prospective evidence, psychosocial stress is thought to elevate the risk of stroke. Job strain, a widely studied form of psychosocial stress, has been linked to an increased risk of coronary heart disease. However, its association …
Adults diagnosed with coronary heart disease, especially before the age of 45, may be at increased risk of developing dementia, Alzheimer’s disease and vascular dementia later in life, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association. Coronary heart …
When Christopher Rajkumar, MD, presented the positive results of ORBITA-2, the second placebo-controlled trial of percutaneous coronary intervention (PCI) in stable angina, you could almost feel the relief of cardiologists at the American Heart Association meeting. All is right again. Thank goodness. The first ORBITA trial stunned our community when it showed that PCI compared …
PHILADELPHIA — Percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD) reduces angina frequency, increases exercise capacity, and improves quality of life, results of a placebo-controlled, randomized trial show, confirming advantages that have never before been proven. “The effect of PCI was immediate, sustained over 12 weeks, and consistent across all endpoints,” …